Laura Sutcliffe
Stock Analyst at UBS
(1.52)
# 3,264
Out of 4,876 analysts
6
Total ratings
66.67%
Success rate
-3.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $290 → $285 | $255.16 | +11.69% | 1 | Apr 24, 2025 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $21 → $22 | $16.01 | +37.41% | 2 | Jan 27, 2025 | |
| ARGX argenx SE | Initiates: Buy | $390 | $560.14 | -30.37% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $28.01 | - | 2 | Dec 20, 2019 |
ResMed
Apr 24, 2025
Maintains: Buy
Price Target: $290 → $285
Current: $255.16
Upside: +11.69%
Telix Pharmaceuticals
Jan 27, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $16.01
Upside: +37.41%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $560.14
Upside: -30.37%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $28.01
Upside: -